inVentiv Health Expedites Site Activation with Veeva Systems
October 18 2016 - 7:03AM
Business Wire
Leading global biopharma outsourcing company
adopts Veeva Vault Study Startup following its success with Veeva
Vault eTMF
2016 Veeva R&D Summit – Today at the Veeva R&D
Summit, to an audience of more than 600 industry leaders, Veeva
Systems (NYSE:VEEV) today announced that inVentiv Health, a leading
biopharma outsourcing company, is expanding its adoption of the
Veeva Vault Clinical Suite to expedite site activation for clients.
inVentiv Health – comprised of a top-tier full-service CRO and the
industry’s only Contract Commercial Organization (CCO) – is
building on its successful use of Veeva Vault eTMF by adopting
Veeva Vault Study Startup to accelerate document-intensive site
activation and speed time to first patient enrollment.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20161018005685/en/
(Graphic: Business Wire)
“We recognized the value an innovative technology solution could
have in knocking down hurdles that slow progress during the study
start-up phase, where improvements can have a significant impact on
overall trial results,” said Rachel Stahler, CIO, inVentiv Health.
“inVentiv identified Veeva as a best-of-breed platform that can
maximize efficiencies and accelerate the delivery of much needed
drugs to patients.”
Vault Study Startup will help inVentiv streamline complex
activities related to site activation, including ethics committee
and Ministry of Health submissions and approvals, document
distribution and tracking, and site contract transactional
activities. Now inVentiv can improve the efficiency of trial
processes by managing documents, data, and study start-up
activities on a single cloud platform, as well as provide
stakeholders easy access to the same, up-to-date clinical
information for improved collaboration. In addition, seamless
interoperability between Vault Study Startup and Vault eTMF ensures
that documents and data are available in both applications.
The current clinical operations environment is highly complex
and often includes upwards of 20 disparate systems to manage trials
– from electronic data capture (EDC) systems and study start-up
applications to clinical trial management systems (CTMS) and
electronic trial master files (eTMF). Legacy technologies limit
efficiency, visibility, and collaboration between sponsors,
investigator sites, and CROs. In fact, in a recent industry-wide
survey, nearly half (49%) of all respondents cited integration
between their eTMF and CTMS applications as a key, unmet need.1
Kristen Jackson, senior director, Essential Document Collection
and Submissions, Site Centricity Unit, inVentiv, will be a speaker
at the 2016 Veeva Global R&D Design Summit in Philadelphia on
October 18 and will discuss these challenges and the benefits of
Vault Study Startup.
About Veeva Vault Clinical Suite
The Veeva Vault Clinical Suite is the only unified suite of
applications on a single cloud platform that streamlines clinical
operations and data management, from study start-up to archive.
Veeva’s clinical operations solutions include Vault eTMF, Vault
Study Startup, and Vault CTMS, while newly announced Veeva Vault
EDC and Veeva Vault eSource will support clinical data management.
Read our press release to learn more about Vault EDC and Vault
eSource and how Veeva will transform clinical data management by
delivering real-time, accurate data to help enable faster, more
informed decisions in clinical trials.
Additional Information
For more on Veeva Vault Study Startup, visit:
veeva.com/studystartup
For more on Veeva Vault eTMF, visit: veeva.com/eTMF
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
Follow us @veevasystems on Twitter: twitter.com/veevasystems
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the
global life sciences industry. Committed to innovation, product
excellence, and customer success, Veeva has more than 450
customers, ranging from the world's largest pharmaceutical
companies to emerging biotechs. Veeva is headquartered in the San
Francisco Bay Area, with offices in Europe, Asia, and Latin
America. For more information, visit www.veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the
market demand for and acceptance of Veeva’s products and services,
the results from use of Veeva’s products and services, and general
business conditions, particularly in the life sciences industry.
Any forward-looking statements contained in this press release are
based upon Veeva’s historical performance and its current plans,
estimates, and expectations, and are not a representation that such
plans, estimates, or expectations will be achieved. These
forward-looking statements represent Veeva’s expectations as of the
date of this press announcement. Subsequent events may cause these
expectations to change, and Veeva disclaims any obligation to
update the forward-looking statements in the future. These
forward-looking statements are subject to known and unknown risks
and uncertainties that may cause actual results to differ
materially. Additional risks and uncertainties that could affect
Veeva’s financial results are included under the captions, “Risk
Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on
Form 10-Q for the period ended July 31, 2016. This is available on
the company’s website at veeva.com under the Investors section and
on the SEC’s website at sec.gov. Further information on potential
risks that could affect actual results will be included in other
filings Veeva makes with the SEC from time to time.
1 Veeva 2016 Paperless TMF Survey: Annual Report (Veeva: June
2016)
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161018005685/en/
Veeva Systems Inc.Roger Villareal,
925-264-8885roger.villareal@veeva.comorLisa Barbadora,
610-420-3413pr@veeva.com
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Apr 2023 to Apr 2024